Online Only Articles

Promising activity of selinexor in the treatment of a patient with refractory diffuse large B-cell lymphoma and central nervous system involvement

Department of Hematology and Vall d’Hebron Institute of Oncology (VHIO), University Hospital Vall d’Hebron, Spain
Department of Hematology and Vall d’Hebron Institute of Oncology (VHIO), University Hospital Vall d’Hebron, Spain
Department of Hematology and Vall d’Hebron Institute of Oncology (VHIO), University Hospital Vall d’Hebron, Spain
Department of Hematology and Vall d’Hebron Institute of Oncology (VHIO), University Hospital Vall d’Hebron, Spain
Department of Pathology, University Hospital Vall d’Hebron, Spain
Laboratory of Experimental Hematology, Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain
Department of Hematology and Vall d’Hebron Institute of Oncology (VHIO), University Hospital Vall d’Hebron, Spain;Laboratory of Experimental Hematology, Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain
Vol. 103 No. 2 (2018): February, 2018 https://doi.org/10.3324/haematol.2017.181636